US 9629877
Human application of engineered chimeric antigen receptor (CAR) T-cells
granted A61KA61K2039/505A61K2239/31
Quick answer
US patent 9629877 (Human application of engineered chimeric antigen receptor (CAR) T-cells) held by The Board of Regents of the University of Texas System expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K2039/505, A61K2239/31, A61K2239/38, A61K2239/57